DIVISLAB.NS
Divi's Laboratories
Health Care · Pharmaceuticals · NSE
$6,521.00
Data: 2026-05-13
✗ ETHICAL FAIL
N/A MOAT
MODERATE
Data Confidence: 71.4%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$1.8T
Total market value of the company
0.00
Rev Growth
0.0%
Year-over-year revenue change
Profit Margin
0.2%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About Divi's Laboratories
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% PASS
Debt must be below 33% of total assets
Cash Ratio
2.5% PASS
Interest-bearing cash below 33% of assets
Receivables
16.1% PASS
Receivables below 49% of assets
Revenue Purity
3.1% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
27.1%
Historical annualised return based on price data
Days in State
27
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
N/A
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | Lakshmi (A) | UNREPORTED | 500 | $35,246 | |
| 2025-12-26 | Sekhar (P Rama) | UNREPORTED | 500 | $35,777 | |
| 2025-12-26 | Sita (Donepudi) | UNREPORTED | 500 | $35,777 | |
| 2025-12-09 | Lakshmi (L) | Promoter | 1,000 | $70,018 | |
| 2025-12-09 | Lingamneni (Sudheer Kumar) | Promoter | 1,000 | $70,018 | |
| 2025-09-10 | Sree (Krishna S) | UNREPORTED | 7,500 | $513,807 | |
| 2025-09-10 | Krishna (Rama S) | UNREPORTED | 2,500 | $171,269 | |
| 2025-06-30 | Sridevi (K) | UNREPORTED | 150 | $11,774 | |
| 2025-06-11 | Sridevi (K) | UNREPORTED | 400 | $31,563 | |
| 2025-06-10 | Vamshi Krishna (Yalavarthi) | UNREPORTED | 200 | $15,608 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-13